Edition:
India

Titan Pharmaceuticals Inc (TTNP.OQ)

TTNP.OQ on NASDAQ Stock Exchange Capital Market

1.08USD
1:30am IST
Change (% chg)

$0.04 (+3.85%)
Prev Close
$1.04
Open
$1.05
Day's High
$1.08
Day's Low
$1.02
Volume
6,470
Avg. Vol
15,811
52-wk High
$2.80
52-wk Low
$0.60

Chart for

About

Titan Pharmaceuticals, Inc. (Titan) is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Company's segment is engaged in the development of pharmaceutical products. The Company's product development programs utilize its long-term drug delivery... (more)

Overall

Beta: 2.14
Market Cap(Mil.): $50.89
Shares Outstanding(Mil.): 21.20
Dividend: --
Yield (%): --

Financials

  TTNP.OQ Industry Sector
P/E (TTM): -- 30.95 32.74
EPS (TTM): -0.54 -- --
ROI: -85.18 14.84 14.38
ROE: -90.44 16.34 16.08

BRIEF-Titan Pharmaceuticals Q4 Loss Per Share $0.17

* TITAN PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

02 Apr 2018

BRIEF-Titan Pharmaceuticals Executes Agreement For Acquisition By Molteni Of Probuphine In Europe And Other Territories

* TITAN EXECUTES AGREEMENT FOR ACQUISITION BY MOLTENI OF PROBUPHINE® IN EUROPE AND OTHER SELECT TERRITORIES

22 Mar 2018

BRIEF-Titan Announces Amendment To Horizon Loan Agreement

* TITAN PHARMACEUTICALS INC - ENTRY INTO AN AMENDMENT TO JULY 2017 LOAN AGREEMENT WITH HORIZON TECHNOLOGY FINANCE CORPORATION

03 Feb 2018

Earnings vs. Estimates